CTIC - CTI BioPharma Corp
Previous close
9.09
9.090 100.000%
Share volume: 0
Last Updated: Fri 23 Jun 2023 08:00:00 PM CEST
Pharmaceutical Preparation Manufacturing :
2.72%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
Summary score
37%
Profitability
43%
Dept financing
41%
Liquidity
23%
Performance
34%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2019 - 2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-32.7%
Return on assets
-20.62%
Return on sales
-702.74%
Return on invested capital
166.38%
Total debt ratio
63.98%
Debt ratio change over timeo
-0.07%
Current Ratio
2.83%
Quick Ratio
2.83%
Cash Position Ratio
2.66%
Short-term ratios 2022 - 2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
168.77%
Return on assets
-10.74%
Return on sales
-80.73%
Return on invested capital
352.71%
Total debt ratio
113.52%
Debt ratio change over timeo
1.16%
Current Ratio
2.34%
Quick Ratio
2.32%
Cash Position Ratio
1.95%
Last quarter ratios 2023
The data are presented for the financials results of the last quarter.
Return on equity
52.95%
Return on assets
-8.22%
Return on sales
-38.28%
Return on invested capital
31.65%
Total debt ratio
122.58%
Debt ratio change over time
2.87%
Current Ratio
1.27%
Quick Ratio
1.26%
Cash Position Ratio
0.86%
Performance ratios (change over 4 years) 2019 - 2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-202.5%
Return on assets
-126.31%
Return on sales
-956.82%
Return on invested capital
108.1%
Total debt ratio
-7.06%
Debt ratio change over time
-0.07%
Current Ratio
2.75%
Quick Ratio
2.74%
Cash Position Ratio
2.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CTIC | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | -32.7% | 0% | 0% | -113.97% |
| Return on assets | -20.62% | 0% | 0% | -11.86% |
| Return on sales | -702.74% | 0% | 0% | -8138.12% |
| Return on invested capital | 166.38% | 0% | 0% | 12.38% |
| Profitability | 25% | 0% | 75% | 2% |
| Total debt ratio | 63.98% | 0% | 0% | 82.24% |
| Debt ratio change over time | -0.07% | 0% | 0% | -0.64% |
| Dept financing | 19% | 0% | 25% | 25% |
| Current Ratio | 2.34% | 0% | 0% | 8.05% |
| Quick Ratio | 2.32% | 0% | 0% | 8.05% |
| Cash Position Ratio | 1.95% | 0% | 0% | 7.86% |
| Liquididy | 27% | 0% | 0% | 75% |
| Short-term ratios | CTIC | VLON | ELAT | RETA |
|---|---|---|---|---|
| Return on equity | 168.77% | 0% | 0% | -409.38% |
| Return on assets | -10.74% | 0% | 0% | -15.5% |
| Return on sales | -80.73% | 0% | 0% | -26031.24% |
| Return on invested capital | 352.71% | 0% | 0% | -122.74% |
| Profitability | 50% | 0% | 50% | 0% |
| Total debt ratio | 113.52% | 0% | 0% | 107.48% |
| Debt ratio change over time | 1.16% | 0% | 0% | -1.94% |
| Dept financing | 50% | 0% | 0% | 24% |
| Current Ratio | 2.34% | 0% | 0% | 8.05% |
| Quick Ratio | 2.32% | 0% | 0% | 8.05% |
| Cash Position Ratio | 1.95% | 0% | 0% | 7.86% |
| Liquididy | 21% | 0% | 0% | 75% |